Press Room

Press Clipping / Sep 26, 2020

Hovione warp-speeds Ligand’s excipient

C&EN, September 26, 2020

Hovione has signed an agreement to significantly ramp up output of Ligand Pharmaceuticals’ Captisol, a chemically modified cyclodextrin that improves drugs’ solubility and stability. Gilead Sciences uses the excipient to formulate the COVID-19 treatment remdesivir. “Hovione will soon be producing per month the quantity it usually produces in one year,” Jean-Luc Herbeaux, its chief operating officer, says in a press release. Hovione is the sole producer of Captisol under a longstanding partnership with Ligand.

 

Read the article on C&EN 

 

 

Also in the Press Room

See All

The partnership with Higuchi forms part of Hovione´s global expansion plans and marks a significant milestone in advancing Hovione's presence in the Japanese market.    Under the terms of the agreement, Higuchi will promote Hovione's pharmaceutical service business throughout Japan, using their extensive experience to enhance brand visibility and attract new clientele across the Japanese pharmaceutical landscape.  “This strategic collaboration underscores Hovione's dedication to delivering innovative solutions and exceptional service to its customers,” said Yuken Kyoyama. “Our partnership with Higuchi will help to show customers in Japan how Hovione can meet their needs.”    Learn more about our business in Japan and visit our website hovione.co.jp    

News
Hovione proudly announces its collaborative venture with Higuchi.

Hovione forges strategic partnership with Higuchi to further strengthen its presence in Japan

Jul 04, 2024

Following the creation of offices in Shanghai and Beijing, Hovione is pleased to announce the launch of its new website in Mandarin. This dedicated platform will enhance Hovione´s presence in China, offering tailored contents to better serve customers in this important market. The new site will provide comprehensive information about Hovione´s products and services, ensuring that Chinese clients have easier access to the innovative solutions and support that Hovione is renowned for worldwide.   “The launch of the Hovione Chinese website underscores our commitment to customers in China,” said Ms. Jackie Liu, Country Head, China. “By delivering localized content and support, we aim to foster stronger partnerships and drive mutual growth in this market. Our team of experts is fully committed to understanding and addressing our clients´ unique challenges with agility and precision.” Visit us at www.hovione.com.cn    

News
Hovione is closer to its customers with a new website in Mandarin

Hovione launches new website for the Chinese Market

Jun 14, 2024

Diane Villax, Co-Founder and Board Member of Hovione has been honored with a lifetime achievement award at Deloitte´s Investor Relations and Governance Awards (IRGAwards) 2024. It was especially fitting for her to receive this prestigious award, which recognizes individuals who have made valuable and exceptional contributions to their field, in the year that Hovione celebrates its 65th anniversary.   Learn more about IRGAwards  

News
36th edition of the Investor Relations & Governance Awards (IRGAwards) promoted by Deloitte

Diane Villax receives achievement award at Deloitte´s Investor Relations and Governance Awards (IRGAwards) 2024

May 23, 2024

Also in Events

See All